| The< i> ALKF1174L</i> Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma T Berry, W Luther, N Bhatnagar, Y Jamin, E Poon, T Sanda, D Pei, ... Cancer cell 22 (1), 117-130, 2012 | 393 | 2012 |
| Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells N Bhatnagar, X Li, SKR Padi, Q Zhang, MS Tang, B Guo Cell death & disease 1 (12), e105, 2010 | 238 | 2010 |
| Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma R Moore, N., Azarova, A., Bhatnagar, N., Ross, K., Drake, L., Frumm, S., Liu ... Oncotarget 5, 2014 | 95 | 2014 |
| 3, 3′-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin N Bhatnagar, X Li, Y Chen, X Zhou, SH Garrett, B Guo Cancer prevention research 2 (6), 581-589, 2009 | 93 | 2009 |
| Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma W Wang, Q Zhong, L Teng, N Bhatnagar, B Sharma, X Zhang, ... Oncogene 1, 9, 2013 | 35 | 2013 |
| The AXL tyrosine kinase receptor contributes to ALK-inhibitor resistance in neuroblastoma. N Bhatnagar, W Luther, B Sharma, Q Liu, N Gray, RE George Cancer Research 73 (8 Supplement), 4454-4454, 2013 | | 2013 |
| The ATP-competitive mTOR inhibitor Torin2 enhances sensitivity of the ALK F1174L mutation to crizotinib in neuroblastoma REG Anna M. Azarova, Namrata Bhatnagar, Lauren Olsen-Drake, Kenneth Ross ... Cancer Research 72 (8), 2012 | | 2012 |
| Regulation of Prostate Cancer Apoptosis and Response to Chemotherapy by MiR-205 and MiR-31 N Bhatnagar Thesis, North Dakota State University, 2010 | | 2010 |
